Published :
Tables : 66
Figures : 44
Category : Healthcare
No. of Pages : 222
Report Code : HC-U3275
Collagen and Gelatin Market for Regenerative Medicine is anticipated to value over USD 990 million by 2027 end with a CAGR of over 8.3% during the forecast period 2020 to 2027. The rising incidences of appalling diseases, rapidly increasing geriatric population, increased private and public financial assistance for developing regenerative medicines are some of the key driving factors of the market. Regenerative medicine promotes the potential restoration of injured tissues and organs. Multiple regenerative therapies for cardiovascular diseases, orthopaedic disorders and wound healing have been introduced over the years and have ben approved by the FDA. The usage of gelatin and collagen-based biomaterials in application related to regenerative medicine have been promoted intensely over the past few years. This method is currently being used on a broader scale for medical and environmental applications, thereby propelling the collagen and gelatin market for regenerative medicine growth. Market Segmentation: By Type • Collagen • Gelatin By Source • Bovine • Porcine • Marine • Others By Application • Wound Care • Orthopaedic • Cardiovascular • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is categorised into type, source, application and region. The type segment is fragmented into collagen and gelatin. The source segment is bifurcated into bovine, porcine ad marine. The bovine source is predicted to account the largest collagen and gelatin market for regenerative medicine share and this is mainly due to the extensive availability and lower cost of bovine products. The application segment is classified into wound care, orthopaedic, cardiovascular and other applications. The orthopaedic segment is anticipated to lead the market, and this can be credited to the increased occurrence of osteoporosis, especially among the ageing population. The rising number of chronic wound cases shall people the growth of the wound care segment during the forecasted timeframe. Furthermore, the gelatin used for caring wounds gives a cooling effect and is also non-adhesive to wound tissues which helps in healing the wound in a shorter time and this shall help in the proliferation of the segment. Regional Analysis: The North America region is expected to dominate the market and tis is due to the rising prevalence of periodontitis, growing incidences of cardiovascular diseases and diabetes owing to lifestyle changes like eating oily and fast foods. However, the Asia Pacific region is predicted to showcase substantial growth during the forecasted timeframe and this is mainly due to the rising diabetic and heart disorder patients in the region, increased research and development activities and key players expanding their businesses in the region. Competitive Landscape: Some of the major market players are GELITA AG, Nitta Gelatin Inc., PB Gelatin, Royal DSM, Integra LifeSciences Holding Corporation, Collagen Solutions plc, Vornia Biomaterials Ltd., Collagen Matrix Inc., SYMATESE, NuCollagen LLC. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global collagen and gelatin market for regenerative medicine market by type, by source, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The rising incidences of appalling diseases, rapidly increasing geriatric population, increased private and public financial assistance for developing regenerative medicines are some of the key driving factors of the market. Regenerative medicine promotes the potential restoration of injured tissues and organs. Multiple regenerative therapies for cardiovascular diseases, orthopaedic disorders and wound healing have been introduced over the years and have ben approved by the FDA. The usage of gelatin and collagen-based biomaterials in application related to regenerative medicine have been promoted intensely over the past few years. This method is currently being used on a broader scale for medical and environmental applications, thereby propelling the collagen and gelatin market for regenerative medicine growth.
Market Segmentation:
By Type • Collagen • Gelatin
By Source • Bovine • Porcine • Marine • Others
By Application • Wound Care • Orthopaedic • Cardiovascular • Others
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is categorised into type, source, application and region. The type segment is fragmented into collagen and gelatin. The source segment is bifurcated into bovine, porcine ad marine. The bovine source is predicted to account the largest collagen and gelatin market for regenerative medicine share and this is mainly due to the extensive availability and lower cost of bovine products. The application segment is classified into wound care, orthopaedic, cardiovascular and other applications. The orthopaedic segment is anticipated to lead the market, and this can be credited to the increased occurrence of osteoporosis, especially among the ageing population. The rising number of chronic wound cases shall people the growth of the wound care segment during the forecasted timeframe. Furthermore, the gelatin used for caring wounds gives a cooling effect and is also non-adhesive to wound tissues which helps in healing the wound in a shorter time and this shall help in the proliferation of the segment.
Regional Analysis:
The North America region is expected to dominate the market and tis is due to the rising prevalence of periodontitis, growing incidences of cardiovascular diseases and diabetes owing to lifestyle changes like eating oily and fast foods. However, the Asia Pacific region is predicted to showcase substantial growth during the forecasted timeframe and this is mainly due to the rising diabetic and heart disorder patients in the region, increased research and development activities and key players expanding their businesses in the region.
Competitive Landscape:
Some of the major market players are GELITA AG, Nitta Gelatin Inc., PB Gelatin, Royal DSM, Integra LifeSciences Holding Corporation, Collagen Solutions plc, Vornia Biomaterials Ltd., Collagen Matrix Inc., SYMATESE, NuCollagen LLC.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global collagen and gelatin market for regenerative medicine market by type, by source, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Collagen and Gelatin Market for Regenerative Medicine Market, By Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Collagen 7.2 Gelatin 8. Collagen and Gelatin Market for Regenerative Medicine Market, By Source Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Bovine 8.2 Porcine 8.3 Marine 8.4 Others 9. Collagen and Gelatin Market for Regenerative Medicine Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Wound Care 9.2 Orthopaedic 9.3 Cardiovascular 9.4 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4. Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 GELITA AG 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Nitta Gelatin Inc. 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 PB Gelatin 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 Royal DSM 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Integra LifeSciences Holding Corporation 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Collagen Solutions plc 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Vornia Biomaterials Ltd. 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 Collagen Matrix Inc. 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9 Symatese 15.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10 NuCollagen LLC. 15.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Research Sources and List of Primary Contacts of this Study 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances
5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges
6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape
7. Collagen and Gelatin Market for Regenerative Medicine Market, By Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Collagen 7.2 Gelatin
8. Collagen and Gelatin Market for Regenerative Medicine Market, By Source Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Bovine 8.2 Porcine 8.3 Marine 8.4 Others
9. Collagen and Gelatin Market for Regenerative Medicine Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Wound Care 9.2 Orthopaedic 9.3 Cardiovascular 9.4 Others
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4. Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 GELITA AG 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Nitta Gelatin Inc. 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 PB Gelatin 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 Royal DSM 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Integra LifeSciences Holding Corporation 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Collagen Solutions plc 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Vornia Biomaterials Ltd. 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 Collagen Matrix Inc. 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9 Symatese 15.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10 NuCollagen LLC. 15.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview
16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies
19. Relevant Case Studies and Latest News Updates
20. Research Sources and List of Primary Contacts of this Study
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics